HCID 70605513, Verbindung → HCID 70604761, Verbindung
Reaktionsgleichung
C([O:4][C@H:5]1[CH2:22][CH2:21][C@@:20]2([CH2:23][O:24][C:25](=[O:27])[CH3:26])[C:7](=[CH:8][CH2:9][C@@H:10]3[C@@H:19]2[CH2:18][CH2:17][C@@:15]2([CH3:16])[C@H:11]3[CH2:12][CH2:13][C@@H:14]2[O:28][C:29](=[O:31])[CH3:30])[CH2:6]1)(=O)C.C(O)(=O)C.C(O)(=O)C.O[C@H]1CC[C@@]2(CO)C(=CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CCC2=O)C1>>[C:29]([O:28][C@H:14]1[CH2:13][CH2:12][C@H:11]2[C@H:10]3[C@H:19]([CH2:18][CH2:17][C@:15]12[CH3:16])[C@:20]1([CH2:23][O:24][C:25](=[O:27])[CH3:26])[C:7]([CH2:6][C@@H:5]([OH:4])[CH2:22][CH2:21]1)=[CH:8][CH2:9]3)(=[O:31])[CH3:30]Komponenten
3
Versuchsvorschrift
Substituting 5-androstene-3β,17β,19-triol triacetate for the 3β,19-dihydroxy-5-androsten-17-one diacetate above results in the preparation of 5-androstene-3β,17β,19-triol 17,19-diacetate.
Quellen und Nachweise
- ORD-Eintrag
- ord-44c113a101bf4acf9ebd389bfacfd743
- Quelldatensatz
- uspto-grants-1979_02
- Patentnummer